Physician profile
Robert L Bauer
NPI 1275018459
$627.12
in general payments reported to CMS, 2019-2025
12 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.81 · 2023: $37.07 · 2024: $115 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $286.38 | 2025 | Senza, Omnia, Vyrsa V1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.81 | 2021 | |
| Mml US, INC. | $45.18 | 2025 | Reactiv8 |
| Abbott Laboratories | $42.87 | 2024 | Proclaim |
| Boston Scientific Corporation | $40.62 | 2024-2025 | Intracept |
| Medtronic, INC. | $31.06 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Vertex Pharmaceuticals Incorporated | $26.83 | 2025 | |
| Scilex Pharmaceuticals INC. | $21.35 | 2024 | |
| Nevro Corp. | $19.96 | 2023 | Senza |
| Si-Bone, INC. | $17.55 | 2025 | |
| Abbvie INC. | $17.40 | 2024 | |
| Spinal Simplicity, LLC | $17.11 | 2023 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.